{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:26:19Z","timestamp":1777562779279,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lymphoproliferative disorder (LPD) has been shown to occur after treatment with methotrexate (MTX). Currently, MTX-LPD has become widely recognized, but its mechanism and prognostic factors remain unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report the first case of Epstein\u2013Barr virus (EBV)-associated MTX-LPD of the breast. A 63-year-old Asian woman with long-term rheumatoid arthritis presented to our facility with intermittent fever. A physical examination revealed a 3-cm lump in her left breast. She had been taking MTX for the past 15 years. Laboratory studies revealed slightly elevated levels of EBV-viral capsid antigen antibody immunoglobulin G and EBV nuclear antibody. Contrast-enhanced computer tomography revealed a mass in the left breast, a subcutaneous nodule in the abdomen, a mass in the left lung, and a nodule in the left retroperitoneum. The definitive diagnosis was consistent with MTX-LPD merging into an EBV-positive, diffuse large B-cell lymphoma. Six months following the withdrawal of MTX, the breast mass had markedly shrunk and the patient remained in good health for 1 year with no evidence of relapse of LPD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>MTX-LPD rarely occurs in the breast, and it is difficult to diagnose because there have only been six reported cases of breast MTX-LPD reported in the literature. EBV-positive MTX-LPD tends to regress spontaneously after MTX withdrawal, and our case also had similar results. It is important to make an appropriate diagnosis of MTX-LPD of the breast based on imaging and pathology to determine the appropriate treatment protocol for this rare disorder.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-022-03274-1","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:02:21Z","timestamp":1644192141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein\u2013Barr virus infection: a case report and review of the\u00a0literature"],"prefix":"10.1186","volume":"16","author":[{"given":"Ayumi","family":"Ogawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Kumaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokuko","family":"Hosoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goshi","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iichiro","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Uetake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"key":"3274_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14397595.2017.1352477","volume":"28","author":"M Harigai","year":"2018","unstructured":"Harigai M. Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: a review of the literature and current perspective. Mod Rheumatol. 2018;28:1\u20138.","journal-title":"Mod Rheumatol"},{"key":"3274_CR2","unstructured":"Swerdlow SH. International Agency for Research on Cancer. WHO classification of tumours of haematopoietic and lymphoid tissues. Rev. 4th ed. International Agency for Research on Cancer. 2017."},{"key":"3274_CR3","first-page":"322","volume":"34","author":"Y Hoshida","year":"2007","unstructured":"Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007;34:322\u201331.","journal-title":"J Rheumatol"},{"key":"3274_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.clbc.2011.01.001","volume":"11","author":"D Pattanaik","year":"2011","unstructured":"Pattanaik D, Koduru S, Azouz A, Patil S, Carbone L. Breast lymphoma complicating anti-tumor necrosis factor therapy in rheumatoid arthritis. Clin Breast Cancer. 2011;11:413\u20136.","journal-title":"Clin Breast Cancer"},{"key":"3274_CR5","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3919\/jjsa.74.1112","volume":"74","author":"T Hashimoto","year":"2013","unstructured":"Hashimoto T, Furui J, Akashi H, et al. A case of synchronous primary breast malignant lymphoma and cecal cancer following methotrexate therapy for rheumatoid arthritis. J Jpn Surg Assoc. 2013;74:1112\u20137.","journal-title":"J Jpn Surg Assoc."},{"key":"3274_CR6","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.3919\/jjsa.76.2892","volume":"76","author":"R Fujimitsu","year":"2015","unstructured":"Fujimitsu R, Takeshita M, Yoshimitsu K. Sequential change in methotrexate-associated lymphoproliferative disorders in bilateral breasts as observed on various imaging modalities: a case report. J Jpn Surg Assoc. 2015;76:2892\u20137.","journal-title":"J Jpn Surg Assoc."},{"key":"3274_CR7","first-page":"191","volume":"42","author":"C Costa","year":"2017","unstructured":"Costa C, Aguiar R, Rodrigues M, et al. Primary breast lymphoma with cutaneous involvement in a patient with rheumatoid arthritis\u2014a complication of infliximab therapy? Acta Reumatol Port. 2017;42:191\u20135.","journal-title":"Acta Reumatol Port"},{"key":"3274_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.clinimag.2018.10.004","volume":"53","author":"RN Matsubayashi","year":"2019","unstructured":"Matsubayashi RN, Iwasaki H, Iwakuma N, Momosaki S. Methotrexate (MTX)-associated malignant lymphoma of the bilateral breast: imaging features in comparison to other nipple-areolar tumors. Clin Imaging. 2019;53:120\u20135.","journal-title":"Clin Imaging"},{"key":"3274_CR9","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3919\/jjsa.80.1965","volume":"80","author":"K Mityake","year":"2019","unstructured":"Mityake K, Aomatsu Y, Nakagawa T, et al. Methotrexate-associated lymphoproliferative disorder diagnosed by breast tumor biopsy: a case report. J Jpn Surg Assoc. 2019;80:1965\u201370.","journal-title":"J Jpn Surg Assoc."},{"key":"3274_CR10","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ejmech.2018.09.027","volume":"158","author":"W Wang","year":"2018","unstructured":"Wang W, Zhou H, Liu L. Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review. Eur J Med Chem. 2018;158:502\u201316.","journal-title":"Eur J Med Chem"},{"key":"3274_CR11","first-page":"1741","volume":"18","author":"MH Ellman","year":"1991","unstructured":"Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol. 1991;18:1741\u20133.","journal-title":"J Rheumatol"},{"key":"3274_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2169\/internalmedicine.54.3361","volume":"54","author":"K Miyagawa","year":"2015","unstructured":"Miyagawa K, Shibata M, Noguchi H, et al. Methotrexate-related primary hepatic lymphoma in a patient with rheumatoid arthritis. Intern Med. 2015;54:401\u20135.","journal-title":"Intern Med"},{"key":"3274_CR13","first-page":"507","volume":"24","author":"H Kuroda","year":"2010","unstructured":"Kuroda H, Sakurai T, Yamada M, et al. Successful rituximab treatment of methotrexate-associated B-cell lymphoproliferative disorder arising in two patients with latency type II Epstein\u2013Barr viral infection. Biotherapy. 2010;24:507\u201311.","journal-title":"Biotherapy"},{"key":"3274_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/01.bor.0000126149.96627.82","volume":"16","author":"MFC Callan","year":"2004","unstructured":"Callan MFC. Epstein\u2013Barr virus, arthritis, and the development of lymphoma in arthritis patients. Curr Opin Rheumatol. 2004;16:399\u2013405.","journal-title":"Curr Opin Rheumatol"},{"key":"3274_CR15","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/ajh.21003","volume":"82","author":"T Miyazaki","year":"2007","unstructured":"Miyazaki T, Fujimaki K, Shirasugi Y, et al. Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein\u2013Barr virus infection. Am J Hematol. 2007;82:1106\u20139.","journal-title":"Am J Hematol"},{"key":"3274_CR16","first-page":"594","volume":"111","author":"Y Ishida","year":"2008","unstructured":"Ishida Y, Asahi A, Wada T, et al. Three cases of methotrexate-associated lymphoproliferative disorders. J Otolaryngol Jpn. 2008;111:594\u20138.","journal-title":"J Otolaryngol Jpn."},{"key":"3274_CR17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/14397595.2016.1259714","volume":"27","author":"T Katsuyama","year":"2017","unstructured":"Katsuyama T, Sada KE, Yan M, et al. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents. Mod Rheumatol. 2017;27:773\u20137.","journal-title":"Mod Rheumatol"},{"key":"3274_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","volume":"104","author":"WY Au","year":"2004","unstructured":"Au WY, Pang A, Choy C, Chim CS, Kwong YL. Quantification of circulating Epstein\u2013Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood. 2004;104:243\u20139.","journal-title":"Blood"},{"key":"3274_CR19","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1148\/rg.2019180097","volume":"39","author":"SD Raj","year":"2019","unstructured":"Raj SD, Shurafa M, Shah Z, Raj KM, Fishman MDC, Dialani VM. Primary and secondary breast lymphoma: clinical, pathologic, and multimodality imaging review. Radiographics. 2019;39:610\u201325.","journal-title":"Radiographics"},{"key":"3274_CR20","first-page":"245","volume":"3","author":"T Shimizu","year":"2014","unstructured":"Shimizu T, Tetsuka T, Ito K, Saito Y, Tsukada H, Ohdaira T. Two cases suspected of methotrexate-associated lymphoproliferative disorders of the lung. Ann Jpn Respir Soc. 2014;3:245\u201350.","journal-title":"Ann Jpn Respir Soc."},{"key":"3274_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00428-016-2030-x","volume":"470","author":"K Ejima-Yamada","year":"2017","unstructured":"Ejima-Yamada K, Oshiro Y, Okamura S, et al. Epstein\u2013Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders. Virchows Arch. 2017;470:205\u201315.","journal-title":"Virchows Arch"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03274-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03274-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03274-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:02:32Z","timestamp":1644192152000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03274-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3274"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03274-1","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]},"assertion":[{"value":"10 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The need of ethical approval is waived off as this is a case report. The authors obtained informed consent from the patient for publication of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}